Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis Venture Fund
Biotech
Protego tucks $130M series B into its fold
Protego Biopharma will use the funding to advance its amyloid light-chain amyloidosis prospect.
Zoey Becker
Dec 1, 2025 6:00am
Versant unveils new autoimmune biotech with $100M fundraise
Apr 24, 2025 8:00am
Atalanta loads crossbow with $97M, 2 Big Pharmas in tow
Jan 28, 2025 7:00am
With $105M and Big Pharma backing, Mediar takes aim at fibrosis
Mar 15, 2023 8:21am
Biotech Oculis sees SPAC potential, signs deal with EBAC
Oct 17, 2022 3:10pm
Novartis-backed ImmPACT Bio gets $111M, ex-Pfizer exec for CEO
Jan 20, 2022 5:00am
